{"id":8271,"date":"2023-11-01T01:55:34","date_gmt":"2023-11-01T00:55:34","guid":{"rendered":"https:\/\/aliber.org\/web\/?p=8271"},"modified":"2023-11-01T01:55:34","modified_gmt":"2023-11-01T00:55:34","slug":"aliber-participa-en-la-asamblea-de-rdi","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2023\/11\/01\/aliber-participa-en-la-asamblea-de-rdi\/","title":{"rendered":"ALIBER Participa en la Asamblea de RDI"},"content":{"rendered":"<div class=\"xdj266r x11i5rnm xat24cr x1mh8g0r x1vvkbs x126k92a\"><\/div>\n<div class=\"x11i5rnm xat24cr x1mh8g0r x1vvkbs xtlvy1s x126k92a\">\n<div dir=\"auto\">\n<p>La Alianza Iberoamericana de Enfermedades Raras, Hu\u00e9rfanas o Poco Frecuentes &#8211; ALIBER participa en la Asamblea de Rare Diseases International &#8211; RDI y en el World Orphan Drug Congress Europe que acoge la ciudad de Barcelona los d\u00edas 30 de octubre, 1 y 2 de noviembre de 2023.<\/p>\n<p>La Alianza est\u00e1 representada por Juan Carri\u00f3n, Presidente de la Alianza Iberoamericana, las dos Vicepresidentas Luz Victoria Salazar y Regina Pr\u00f3spero, al igual que Vanessa Valencia de aYOUDas Panam\u00e1, Fide Mir\u00f3n de FEDER y David S\u00e1nchez de Aliber Retina Murcia.<\/p>\n<p>Todos ellos han tenido la oportunidad de generar un espacio de encuentro donde trabajar en el Plan estrat\u00e9gico que va a implementar la RDI en el pr\u00f3ximo a\u00f1o 2024.<\/p>\n<p>Pacientes y L\u00edderes de todo el Movimiento Asociativo a nivel mundial unidos.<\/p>\n<\/div>\n<\/div>\n<div class=\"x11i5rnm xat24cr x1mh8g0r x1vvkbs xtlvy1s x126k92a\">\n<div dir=\"auto\"><\/div>\n<div dir=\"auto\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-8272 size-full\" src=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2023\/11\/asamblea-rdi.jpg\" alt=\"\" width=\"1079\" height=\"806\" srcset=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2023\/11\/asamblea-rdi.jpg 1079w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2023\/11\/asamblea-rdi-300x224.jpg 300w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2023\/11\/asamblea-rdi-1024x765.jpg 1024w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2023\/11\/asamblea-rdi-768x574.jpg 768w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2023\/11\/asamblea-rdi-285x214.jpg 285w\" sizes=\"(max-width: 1079px) 100vw, 1079px\" \/>Todos ellos han tenido la oportunidad de generar un espacio de encuentro donde trabajar en el Plan estrat\u00e9gico que va a implementar la RDI en el pr\u00f3ximo a\u00f1o 2024.<\/div>\n<\/div>\n<div class=\"x11i5rnm xat24cr x1mh8g0r x1vvkbs xtlvy1s x126k92a\">\n<div dir=\"auto\">Pacientes y L\u00edderes de todo el Movimiento Asociativo a nivel mundial unidos.<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La Alianza Iberoamericana de Enfermedades Raras, Hu\u00e9rfanas o Poco Frecuentes &#8211; ALIBER participa en la Asamblea de Rare Diseases International &#8211; RDI y en el World Orphan Drug Congress Europe<a href=\"https:\/\/aliber.org\/web\/2023\/11\/01\/aliber-participa-en-la-asamblea-de-rdi\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":2,"featured_media":8272,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-8271","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aliber"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/8271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=8271"}],"version-history":[{"count":3,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/8271\/revisions"}],"predecessor-version":[{"id":8275,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/8271\/revisions\/8275"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media\/8272"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=8271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=8271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=8271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}